mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.6 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.6 |
mRNA |
QS11 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.6 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |